Vertex Pharmaceuticals (VRTX) Tax Rate (2011 - 2026)
Vertex Pharmaceuticals (VRTX) posted quarterly Tax Rate of 17.68% for Q1 2026, up 616.0% year-over-year from 2.47% in Q1 2025, and up 68.2% quarter-over-quarter from 10.51% in Q4 2025.
Vertex Pharmaceuticals (VRTX) Tax Rate (2011 - 2026) Analysis & Trends
Vertex Pharmaceuticals' Tax Rate history runs 16 years deep, the most recent figure standing at 17.68% for Q1 2026.
- In Q1 2026, Tax Rate rose 616.0% year-over-year to 17.68%; the TTM figure through Mar 2026 stood at 16.02% (up 24543.0% YoY), while the FY2025 annual figure was 14.86%, down 30067.0% from the prior year.
- Tax Rate for Q1 2026 stood at 17.68%, up from 10.51% in the prior quarter.
- The five-year high for Tax Rate was 23.95% in Q4 2022, with the low at 5.97% in Q2 2024.
- The 5-year median for Tax Rate is 17.68% (2026), against an average of 16.15%.
- The sharpest annual moves came in 2022 and 2025: Tax Rate plunged 23070 bps in 2022, then jumped 2546 bps in 2025.
- Vertex Pharmaceuticals' Tax Rate stood at 23.95% in 2022, then tumbled by 35 bps to 15.58% in 2023, then gained by 26 bps to 19.67% in 2024, then plunged by 47 bps to 10.51% in 2025, then soared by 68 bps to 17.68% in 2026.
- Business Quant data shows VRTX's Tax Rate at 17.68% in Q1 2026, 10.51% in Q4 2025, and 16.62% in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Tax Rate (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 20.98% |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 15.11% |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 10.91% |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 24.15% |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -9.47% |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 7.49% |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -16.71% |
| 10 | Roivant Sciences | 26.16 Bn | 26.85 Bn | 1.16 Mn | 1.34% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 20.98% |
| Jun 30, 2026 | 20.98% |
| Jun 30, 2026 | 20.98% |
| Mar 31, 2026 | 17.68% |
| Mar 31, 2026 | 17.68% |
| Mar 31, 2026 | 17.68% |
| Dec 31, 2025 | 10.51% |
| Dec 31, 2025 | 10.51% |
| Dec 31, 2025 | 10.51% |
| Sep 30, 2025 | 16.62% |
| Sep 30, 2025 | 16.62% |
| Sep 30, 2025 | 16.62% |
| Jun 30, 2025 | 19.49% |
| Jun 30, 2025 | 19.49% |
| Jun 30, 2025 | 19.49% |
| Mar 31, 2025 | 11.51% |
| Mar 31, 2025 | 11.51% |
| Mar 31, 2025 | 11.51% |
| Dec 31, 2024 | 19.67% |
| Dec 31, 2024 | 19.67% |